Skip to content
healthcare.dev

Terbinafine

NDC 76282-209, Terbinafine, tablet, from Exelan Pharmaceuticals Inc..

Product NDC
76282-209
Status
Listed
Labeler
Exelan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERBINAFINE HYDROCHLORIDE250 mg/1

Pharmacologic classes

Allylamine Antifungal [EPC]; Allylamine [CS]

Package NDCNDC-11Package
76282-209-0176282020901100 TABLET in 1 BOTTLE (76282-209-01)
76282-209-0576282020905500 TABLET in 1 BOTTLE (76282-209-05)
76282-209-307628202093030 TABLET in 1 BOTTLE (76282-209-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6dc279cc-9861-4fa8-8083-ca3b3c57b513

Use it

Look up 76282-209 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.